In vitro induction of a bladder cancer-specific T-cell response by mRNA-transfected dendritic cells
/in Dendritic Cells, International Publications, Urothelial CarcinomaDendritic cells derived from multiple myeloma patients efficiently internalize different classes of myeloma protein
/in Dendritic Cells, International Publications, Multiple MyelomaImmunotherapy of bladder cancer using autologous dendritic cells pulsed with human lymphocyte antigen-A24-specific MAGE-3 peptide
/in Dendritic Cells, International Publications, Urothelial CarcinomaTreatment of a patient by vaccination with autologous dendritic cells pulsed with allogeneic major histocompatibility complex class I-matched tumor peptides. Case Report
/in Dendritic Cells, Glioblastoma, International PublicationsInduction of cytotoxic T-lymphocyte responses in vivo after vaccinations with peptide-pulsed dendritic cells
/in Breast Cancer, Dendritic Cells, International Publications, Ovarian CancerVaccination of multiple myeloma patients with idiotype-pulsed dendritic cells: immunological and clinical aspects
/in Dendritic Cells, International Publications, Multiple MyelomaDendritic cell biology and the application of dendritic cells to immunotherapy of multiple myeloma
/in Dendritic Cells, International Publications, Multiple MyelomaGeneration of anti-idiotype immune responses following vaccination with idiotype-protein pulsed dendritic cells in myeloma
/in Dendritic Cells, International Publications, Multiple Myeloma
IMMUN-ONKOLOGISCHES ZENTRUM KÖLN
Hohenstaufenring 30–32
50674 Köln | Deutschland
T: +49 (0)221 – 420 399 25
E-Mail: info@iozk.de
Hohenstaufenring 30–32
50674 Köln | Deutschland
T: +49 (0)221 – 420 399 25
E-Mail: info@iozk.de
Die IOZK Immuntherapie
Aktuelles und Int. Publikationen
- WT1-mRNA dendritic cell vaccination of patients with glioblastoma multiforme, malignant pleural mesothelioma, metastatic breast cancer, and other solid tumors: type 1 T-lymphocyte responses are associated with clinical outcome
- Autologous tumor lysate-loaded dendritic cell vaccination in glioblastoma patients: a systematic review of literature
- Retrospective Analysis of HLA Class II-Restricted Neoantigen Peptide-Pulsed Dendritic Cell Vaccine for Breast Cancer